Altair Nanotechnologies Inc
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
____________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of
Report (date of earliest event reported):
November 11, 2005
Altair
Nanotechnologies Inc.
(Exact
Name of Registrant as Specified in its Charter)
Canada
|
|
1-12497
|
|
33-1084375
|
(State
or other jurisdiction of
|
|
(Commission
File
Number)
|
|
(IRS
Employer Identification
No.)
|
incorporation
or organization)
|
|
|
|
|
204
Edison Way
|
|
|
Reno,
NV
|
|
89502
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant's
Telephone Number, Including Area Code:
(Former
name, former address, and formal fiscal year, if changed since last
report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see
General
Instruction A.2. below):
|
o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
|
o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
|
|
o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
|
|
o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c)
|
Item
2.02 Results of Operations and Financial Condition.
On
November 11, 2005, Altair Nanotechnologies, Inc. (the "Company") issued a press
release entitled "Altair Nanotechnologies Reports Third Quarter Fiscal 2005
Financial Results.” The full text of the press release is provided herewith as
Exhibit 99.1.
The
information in Item 2.02 of this Report (including exhibit 99.1) shall not
be
deemed to be "filed" for purposes of Section 18 of the Securities Exchange
Act
of 1934, as amended (the "Exchange Act"), or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference
in
any filing made by the Company under the Securities Act of 1933, as amended,
or
the Exchange Act, except as expressly set forth by specific reference in such
a
filing.
Item
9.01 Financial Statements and Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange of 1934, the registrant has
duly
caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
ALTAIR
NANOTECHNOLOGIES, INC. |
|
|
|
Dated:
November 14, 2005 |
By: |
/s/ Edward
Dickinson |
|
|
|
Edward
Dickinson, Chief Financial Officer |
-3-